Skip to content
Subscriber Only
Business
Prognosis

Sanofi Vaccine Partner Translate Bio Cites Antibody Response

Virus Ramps Up Medical Glassware Manufacture At Gerresheimer AG
Photographer: Alex Kraus/Bloomberg

An experimental coronavirus vaccine developed by Translate Bio Inc. and French drug giant Sanofi induced high levels of protective neutralizing antibodies in early-stage animal studies, according to a regulatory filing.

Translate Bio cited Sanofi slides highlighting preclinical data on the messenger RNA vaccine, which prompts the body to make a key protein from the virus, sparking an immune response. Sanofi was expected to present data at an event on Tuesday, according to the filing. The experimental shot is based on technology similar to that used by one of the front-runners, Moderna Inc.